Richard Felton

David Adlington

Dylan van Haaften

Graham Doyle

Hassan Al-Wakeel

Jack Reynolds-Clark

Kane Slutzkin

Robert Davies

Sam England

Veronika Dubajova

Julien Dormois

Lisa Clive

Samuel England

Sezgi Ozener

- Smith+Nephew announced that the American Medical Association (AMA) CPT Editorial Panel has established a **Category I Current Procedural Terminology (CPT) code** for procedures involving its CARTIHEAL AGILI-C Cartilage Repair Implant, effective **January 1, 2027**.  **[845982_4c159ed6b4da45978adbc35646148af0_0]** 
- The CARTIHEAL Implant is the **only FDA-approved device** for treating cartilage and osteochondral defects in the knee, including in patients with mild to moderate osteoarthritis, and demonstrated an **87% reduction in the relative risk of total knee arthroplasty or osteotomy** at 4 years in clinical trials.  **[845982_4c159ed6b4da45978adbc35646148af0_0]** 
- This new CPT code is expected to **streamline reimbursement processes** for providers and payers, facilitating broader access and integration of the CARTIHEAL Implant into standard clinical practice.  **[845982_4c159ed6b4da45978adbc35646148af0_0]**

Smith+Nephew Secures Category I CPT Code for CARTIHEAL Implant

- The global **Advanced Wound Care Market** was valued at **$5.14 billion in 2024** and is projected to grow to **$7.47 billion by 2032**, exhibiting a **Compound Annual Growth Rate (CAGR) of 4.8%** from 2025 to 2032.  **[845982_2a10642e0f754ae68b9e6c592d5521e7_0]** **[845982_2a10642e0f754ae68b9e6c592d5521e7_1]** 
- This market growth is primarily driven by the **increasing prevalence of chronic wounds**, aging populations, and expanding access to advanced wound care therapies, including advancements in biologics, smart dressings, and regenerative technologies.  **[845982_2a10642e0f754ae68b9e6c592d5521e7_0]** 
- **North America** held the largest market share at **46.05% in 2024**, while **Asia Pacific** is anticipated to experience the **fastest growth** during the forecast period.  **[845982_2a10642e0f754ae68b9e6c592d5521e7_1]** 
- **Smith & Nephew PLC** is identified as a major player in the Advanced Wound Care Market and recently received **FDA clearance for a bioactive skin substitute** designed to significantly reduce healing time in diabetic ulcers.  **[845982_2a10642e0f754ae68b9e6c592d5521e7_0]** **[845982_2a10642e0f754ae68b9e6c592d5521e7_2]**

SNN: Advanced Wound Care Market Projected to Reach $7.47 Billion by 2032

SMITH & NEPHEW (SNN)